FDA, NIH Respond to Charges of Lax Oversight

The FDA and the National Institutes of Health don't agree with allegations that sponsors of clinical trials are not adhering to a federal law that requires public reporting of clinical trial data within one year of completion.

Both agencies wrote letters to Congress disputing charges leveled against them in an analysis published in January in BMJ that found that neither government-funded nor privately-funded studies for pre-approved drugs were being reported in a timely manner, according to an article published online this week in Nature.

Read the full story: http://hcp.lv/IPjReJ

Source: MedPage Today